Drug Discovery and Development of Innovative Therapeutics INDIA
Event Information
|
October 20 - 22, 2008 Grand Hyatt Hotel · Mumbai, India |
Alternate Language Options:
|
Document Title
Conference Advisory Board
- Bharatt M. Chowrira, Ph.D., Vice President, Sirna Therapeutics and Executive Director, Worldwide Licensing and External Research, Merck & Co., USA
- Yetunde Taiwo, Ph.D., Director, Global External Research & Development, Eli Lilly and Company, USA
- Uday Saxena, Ph.D., Co-Founder and CEO, Kareus Therapeutics, USA
- Sri Mosur, CEO, Jubilant Biosys, India
- CSN Murthy, Chief Executive Officer, Aurigene Discovery Technologies, India
- Suri Venkatachalam, Ph.D., CEO and Managing Director, Connexios Life Sciences, India
- CB Rao, Ph.D., Chief Mentor, Orchid Research Laboratories, India
- Venkat Jasti, CEO, Suven Life Sciences Limited, India
- Bruce Murdoch, Chief Business Officer, Avesthagen, India
- Chetak Buaria, General Manager, Corporate Business Development, Merck KgA Limited, India
- Binu Philip, Manager, Business Development, Zydus Research Centre, India
- Kiran Mazumdar-Shaw, Chairman, Biocon, India
- Rashmi H. Barbhaiaya, Ph.D., CEO and Managing Director, Advinus Therapeutics, India
- Swaroop Kumar, Ph.D., CEO, Zanthera Pharmaceuticals, India
- Tanjore Balganesh, Ph.D.,Vice President, Discovery, AstraZeneca, India
- M. Vidyasagar, Executive Vice President, Tata Consultancy Services, India
Bottom menu
Copyright IBC Life Sciences, a part of Informa Life Sciences Group